Elanco Animal Health (ELAN) Share-based Compensation Growth (1y) (2018 - 2026)
Elanco Animal Health (ELAN) Share-based Compensation Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.01 Bn | 87.15 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 26.47% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 47.06% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | 8.79% |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | 281.05% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | 92.83% |
| 8 | Neurocrine Biosciences | 17.73 Bn | 16.41 Bn | 800.70 Mn | 5.49% |
| 9 | Elanco Animal Health | 12.56 Bn | 12.14 Bn | 785.00 Mn | 61.54% |
| 10 | Vireo Growth | 10.48 Bn | 10.33 Bn | 59.30 Mn | 438.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.54% |
| Dec 31, 2025 | 6.67% |
| Sep 30, 2025 | 13.33% |
| Jun 30, 2025 | 57.14% |
| Mar 31, 2025 | 18.18% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 50.00% |
| Jun 30, 2024 | 55.56% |
| Mar 31, 2024 | -8.33% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -23.08% |
| Jun 30, 2023 | -47.06% |
| Mar 31, 2023 | -14.29% |
| Dec 31, 2022 | -16.67% |
| Sep 30, 2022 | -23.53% |
| Jun 30, 2022 | 6.25% |
| Mar 31, 2022 | -6.67% |
| Dec 31, 2021 | 12.50% |
| Sep 30, 2021 | 41.67% |
| Jun 30, 2021 | 100.00% |